Answers are grounded in this paper and cite their sources.
In hypercholesterolaemic patients, the liver-selective thyromimetic eprotirome decreased serum levels of atherogenic lipoproteins without signs of extra-hepatic side effects. Selective stimulation of hepatic thyroid hormone receptors may be an attractive way to modulate lipid metabolism in hyperlipidaemia.
No takes yet. Share an insight, caveat, or question.
Angelin et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: